ELVN - Enliven Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$69.20
DETAILS
HIGH:
$80.00
LOW:
$59.00
MEDIAN:
$65.00
CONSENSUS:
$69.20
UPSIDE:
37.03%
Metrics Summary
Market Cap:
3.61B
Volume:
283,380
Avg Volume:
1,346,432
52 Week Range:
14.785-52.39
Sector:
Healthcare
Industry:
Biotechnology
Beta:
0.26
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
62
IPO Date:
2020-03-12